Catalent to Acquire Cook Pharmica for $950 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Catalent (CTLT) PT Raised to $45 at BofA/Merrill Lynch Following Announced Plans to Acquire Pharmica
September 20, 2017 9:19 AM EDTBofA/Merrill Lynch raised its price target on Catalent (NYSE: CTLT) to $45.00 (from $40.00) while maintaining a Buy rating following the company's announced its intention to acquire Cook Pharmica for $950 in cash. CTLT expects the incremental free cash flow generation to assist in deleveraging,... More
